Does VALPROATE Cause Hyperammonaemic encephalopathy? 120 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 120 reports of Hyperammonaemic encephalopathy have been filed in association with VALPROATE (Valproate Sodium). This represents 0.8% of all adverse event reports for VALPROATE.
120
Reports of Hyperammonaemic encephalopathy with VALPROATE
0.8%
of all VALPROATE reports
4
Deaths
80
Hospitalizations
How Dangerous Is Hyperammonaemic encephalopathy From VALPROATE?
Of the 120 reports, 4 (3.3%) resulted in death, 80 (66.7%) required hospitalization, and 18 (15.0%) were considered life-threatening.
Is Hyperammonaemic encephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALPROATE. However, 120 reports have been filed with the FAERS database.
What Other Side Effects Does VALPROATE Cause?
Foetal exposure during pregnancy (1,982)
Drug ineffective (1,268)
Seizure (1,083)
Epilepsy (878)
Somnolence (843)
Off label use (744)
Drug abuse (705)
Sopor (577)
Dysmorphism (552)
Drug interaction (513)
What Other Drugs Cause Hyperammonaemic encephalopathy?
VALPROIC ACID (455)
FLUOROURACIL (156)
DIVALPROEX (119)
OXALIPLATIN (107)
TOPIRAMATE (101)
RISPERIDONE (96)
QUETIAPINE (91)
LEVETIRACETAM (71)
LEUCOVORIN (62)
CAPECITABINE (60)
Which VALPROATE Alternatives Have Lower Hyperammonaemic encephalopathy Risk?
VALPROATE vs VALPROIC ACID
VALPROATE vs VALPROMIDE
VALPROATE vs VALSARTAN
VALPROATE vs VALTREX
VALPROATE vs VAMOROLONE